Viewing Study NCT00332969


Ignite Creation Date: 2025-12-24 @ 10:52 PM
Ignite Modification Date: 2025-12-25 @ 8:21 PM
Study NCT ID: NCT00332969
Status: COMPLETED
Last Update Posted: 2017-03-31
First Post: 2006-06-01
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Efficacy of Octreotide Treatment in Patients With Primary Inoperable Thymoma
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module